GGrantIndex
Sort

64,565 grants matching drug discovery

Genetically-encoded fluorescent RNA sensors for measuring transport of antibiotics into the cytoplasm of Gram-negative pathogens and development of efflux pump inhibitors

$842,084
Stephen Lory · Harvard Medical School · R01 · FY2019 · AI

BMC--BHASIN

$842,060
Shalendar Bhasin · Boston Medical Center · P30 · FY2010 · AG

GENETICS OF ADOLESCENT ANTISOCIAL DRUG DEPENDENCE

$842,028
University Of Colorado Denver · R01 · FY2004 · DA

Geisinger eGenonic Medicine (GeM) Program

$841,817
David J. Carey · Geisinger Clinic · U01 · FY2011 · HG

A systems analysis of drug tolerance in Mycobacterium tuberculosis

$841,703
Nitin S Baliga · Institute For Systems Biology · R01 · FY2025 · AI

Identifying novel anti-infectives by high through-put screening in whole animals

$841,655
Frederick M Ausubel · Massachusetts General Hospital · R01 · FY2009 · AI

Center for Applied Preclinical Research (CAPR)

$841,462
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

Molecular and immune drivers of immunotherapy responsiveness in prostate cancer

$841,459
Eliezer M Van Allen · Dana-Farber Cancer Inst · U01 · FY2018 · CA

Biological annotation of TCGA data

$841,452
Gordon B. Mills · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · CA

Drug Discovery & Synthesis of Contraceptive Agents

$841,422
Gunda I. Georg · University Of Minnesota · U01 · FY2013 · HD

Genetic Analysis of Attention Deficit Hyperactivity Disorder

$841,394
Maximilian Muenke · National Human Genome Research Institute · ZIA · FY2012 · HG

Small Molecule Therapeutics for Renal Disease

$841,379
Prakash Narayan · Angion Biomedica Corporation · R44 · FY2009 · DK

Bridging pharmacodynamic biomarkers to clinical outcomes in pediatric inflammatory diseases

$841,359
John N Van Den Anker · Children'S Research Institute · U54 · FY2016 · HD

Identifying driver mutations and tumor dependencies by comparative oncogenomics.

$841,281
Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2011 · CA

Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis

$841,154
Afshin Dowlati · Case Western Reserve University · U01 · FY2013 · CA

NIDA Epidemiology Training Program

$841,140
Renee M. Johnson · Johns Hopkins University · T32 · FY2015 · DA

Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV

$841,127
John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK

Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV

$841,127
John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK

Intensive longitudinal study of suicidal behaviors and related health outcomes

$841,101
Matthew K Nock · Harvard University · U01 · FY2018 · MH

Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells

$840,979
Carol Prives · Columbia Univ New York Morningside · R35 · FY2020 · CA

SPORE IN BREAST CANCER

$840,943
Baylor College Of Medicine · P50 · FY2002 · CA

Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology

$840,738
Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2022 · HL

Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology

$840,738
Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2023 · HL

Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology

$840,738
Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2021 · HL

Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’

$840,469
Jian Li · Monash University · R01 · FY2020 · AI